Pakistan to start private imports of China's CanSino COVID-19 jab for sale | Inquirer News

Pakistan to start private imports of China’s CanSino COVID-19 jab for sale

/ 09:51 PM March 22, 2021

Pakistan to start private imports of China's CanSino COVID-19 jab for sale

A resident receives a dose of coronavirus disease (COVID-19) vaccine, at a vaccination center in Karachi, Pakistan March 22, 2021. REUTERS/Akhtar Soomro

ISLAMABAD A private company in Pakistan will begin receiving shipments of China’s CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the company’s local partner told Reuters on Monday.

Pakistan, one of the first countries in the world to allow private imports of COVID-19 vaccines, has already received a batch of the Russian Sputnik vaccine.

Article continues after this advertisement

“We expect the first 10,000 doses to come on March 25, and 100,000 next month and 200,000 the month after,” said Hassan Abbas, an official of AJ Pharma, CanSino’s local partner, which will be importing the vaccine.

FEATURED STORIES

“The issues with pricing have been worked out with the government and now we are waiting for a notification.”

The vaccine’s commercial name will be “Convidecia,” Abbas said, adding that five hospitals that ran its clinical trials will provide its doses for sale.

Article continues after this advertisement

Pakistan is in the process of vaccinating frontline healthcare workers and citizens over the age of 60 free of charge using Sinopharm doses donated by China.

Article continues after this advertisement

The commercial administration of vaccines is yet to begin as the government settles pricing issues, after reversing its decision to allow uncapped prices.

Article continues after this advertisement

The government has approved a mechanism to fix open market prices for the vaccines, according to a health ministry summary seen by Reuters.

The summary proposed a price of 8,449 rupees ($54.30) per pack of two injections of the Russian vaccine and 4,225 ($27.15) per injection for the Chinese Convidecia.

Article continues after this advertisement

The prices have been capped on the basis of the approved mechanism, it said.

However, the minister in charge of COVID operations, Asad Umar, told a local TV channel that according to the mechanism, the trade price for an imported vaccine will add 40% mark up in the landed cost, with another 15% for retailers or hospitals.

CanSino Biologics and Pakistan’s Health Minister Faisal Sultan did not immediately respond to requests for comment.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Pakistan is experiencing a sharp rise in COVID-19 infections, reporting on Saturday the highest number of positive cases in a day since July.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: CanSino, China, Coronavirus, COVID-19, Health, Pakistan, pandemic, SARS-CoV-2, vaccine, Virus

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.